Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 676 AL 690

Implications of nocturnal symptoms towards the early diagnosis of Parkinson's disease

Slow EJ, Postuma RB, Lang AE.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S49-57. doi: 10.1007/s00702-014-1168-4. Epub 2014 Feb 6.

Parkinson's disease associated with myasthenia gravis and rheumatoid arthritis

Zis P, Argiriadou V, Temperikidis PP, Zikou L, Tzartos SJ, Tavernarakis A.

Neurol Sci. 2014 May;35(5):797-9. doi: 10.1007/s10072-014-1660-5. Epub 2014 Feb 6.

Lipid dysfunction and pathogenesis of multiple system atrophy

Bleasel JM, Wong JH, Halliday GM, Kim WS.

Acta Neuropathol Commun. 2014 Feb 7;2:15. doi: 10.1186/2051-5960-2-15.

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

Reeve A, Simcox E, Turnbull D.

Ageing Res Rev. 2014 Mar;14(100):19-30. doi: 10.1016/j.arr.2014.01.004. Epub 2014 Feb 3.

Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach

Baltazar MT, Dinis-Oliveira RJ, de Lourdes Bastos M, Tsatsakis AM, Duarte JA, Carvalho F.

Toxicol Lett. 2014 Oct 15;230(2):85-103. doi: 10.1016/j.toxlet.2014.01.039. Epub 2014 Feb 3.

Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients

Hsiao IT, Weng YH, Lin WY, Hsieh CJ, Wey SP, Yen TC, Kung MP, Lu CS, Lin KJ.

Nucl Med Biol. 2014 Apr;41(4):322-9. doi: 10.1016/j.nucmedbio.2013.12.017. Epub 2014 Jan 10.

Reduction of parkinsonism and psychosis with mirtazapine: a case report

Godschalx-Dekker JA, Siegers HP.

Pharmacopsychiatry. 2014 May;47(3):81-3. doi: 10.1055/s-0034-1367014. Epub 2014 Feb 6.

[Proteomic biomarkers in Parkinson's disease]

Bandrés S, Durán R, Barrero F, Ramírez M, Vives F.

Rev Neurol. 2014 Feb 16;58(4):166-74.

Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons

Hegarty SV, Sullivan AM, O'Keeffe GW.

Mol Neurobiol. 2014 Oct;50(2):559-73. doi: 10.1007/s12035-014-8639-3. Epub 2014 Feb 7.

SIRT1 in neurodevelopment and brain senescence

Herskovits AZ, Guarente L.

Neuron. 2014 Feb 5;81(3):471-83. doi: 10.1016/j.neuron.2014.01.028.

A comparison of caregiver burden in older persons and persons with Parkinson's disease or dementia in sub-Saharan Africa

Dotchin CL, Paddick SM, Longdon AR, Kisoli A, Gray WK, Dewhurst F, Chaote P, Dewhurst M, Walker RW.

Int Psychogeriatr. 2014 Apr;26(4):687-92. doi: 10.1017/S104161021300255X. Epub 2014 Feb 10.

Parkinson's with tardive Creutzfeldt-Jakob disease: when there is more to it than meets the eye

Laurencin C, Broussolle E, Streichenberger N, Thobois S, Quadrio I, Poisson A.

Rev Neurol (Paris). 2014 Feb;170(2):148-50. doi: 10.1016/j.neurol.2013.08.008. Epub 2014 Feb 5.

Postural rehabilitation and Kinesio taping for axial postural disorders in Parkinson's disease

Capecci M, Serpicelli C, Fiorentini L, Censi G, Ferretti M, Orni C, Renzi R, Provinciali L, Ceravolo MG.

Arch Phys Med Rehabil. 2014 Jun;95(6):1067-75. doi: 10.1016/j.apmr.2014.01.020. Epub 2014 Feb 5.

Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?

Rizzone MG, Fasano A, Daniele A, Zibetti M, Merola A, Rizzi L, Piano C, Piccininni C, Romito LM, Lopiano L, Albanese A.

Parkinsonism Relat Disord. 2014 Apr;20(4):376-81. doi: 10.1016/j.parkreldis.2014.01.012. Epub 2014 Jan 23.

Effect of nicotine on L-dopa-induced dyskinesia in animal models of Parkinson's disease: a systematic review and meta-analysis

Xie CL, Pan JL, Zhang SF, Gan J, Liu ZG.

Neurol Sci. 2014 May;35(5):653-62. doi: 10.1007/s10072-014-1652-5. Epub 2014 Feb 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias